Clinical Trial Update: Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity [Phase 2]

View source ↗

Summary

Phase 2 study to evaluate the efficacy and safety of oral KAI-7535 in adults with obesity or overweight and at least one weight-related comorbidity; the trial s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• KAI-7535

Snippet

Sponsor: Kailera | Conditions: Obesity, Overweight | Phase 2 | Status: NOT_YET_RECRUITING